➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
Merck
McKesson
Mallinckrodt

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

CEFUROXIME SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefuroxime sodium and what is the scope of patent protection?

Cefuroxime sodium is the generic ingredient in seven branded drugs marketed by B Braun, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, Teva Pharms, Watson Labs Inc, Samson Medcl, Acs Dobfar, Lilly, and Teligent, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-two drug master file entries for cefuroxime sodium. Two suppliers are listed for this compound.

Recent Clinical Trials for CEFUROXIME SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital Universitari Vall d'Hebron Research InstitutePhase 4
University Hospital, Basel, SwitzerlandPhase 4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2/Phase 3

See all CEFUROXIME SODIUM clinical trials

Pharmacology for CEFUROXIME SODIUM

US Patents and Regulatory Information for CEFUROXIME SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent ZINACEF cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050558-002 Oct 19, 1983 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent ZINACEF cefuroxime sodium INJECTABLE;INJECTION 050558-004 Oct 23, 1986 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hikma Farmaceutica CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065048-001 Jan 9, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Lilly KEFUROX IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INTRAVENOUS 062590-001 Jan 10, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Samson Medcl CEFUROXIME SODIUM IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 065251-001 Dec 30, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INJECTION 065001-002 May 30, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly KEFUROX cefuroxime sodium INJECTABLE;INTRAVENOUS 062592-001 Jan 10, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Colorcon
Express Scripts
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.